Epilepsy study seeks best method to spot hidden anxiety and depression

NCT ID NCT05864612

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested four different ways to deliver anxiety and depression screening questionnaires to adults with epilepsy before their clinic visits. Researchers wanted to see which method led to the highest completion rates. The goal is to make mental health screening easier and more effective in epilepsy care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Screening Questionnaires
What this could lead to
If successful, this could help clinics choose the best way to screen epilepsy patients for anxiety and depression, improving mental health care.
What could go wrong
This is a completed study focused on comparing screening methods, not testing a treatment. It may not directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Atrium Health Wake Forest Baptist

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.